Volume : 09, Issue : 06, June – 2022



Authors :

Khan Fahaad Hassan*, Sailesh kumar Ghatuary, Satkar Prasad,Kalpana Prajapati

Abstract :

The intention of research was to design and development of sustained release multi- component drug delivery system using hot melt coating technique. Hot melt coating technique was used initially to formulate sustained release drug delivery system of ofloxacin and finally to formulate sustained release multi- component drug delivery system of rifampicin plus isoniazid and metoprolol tartrate plus hydrochlorothiazide respectively. Ofloxacin pellets were prepared by rotary shaker pelletizer and hot melt coated with different coating levels of various ratios of stearic acid: palmitic acid. Ofloxacin hot melt coated pellets were spherical with smooth surface and also complies parametric standards for hardness, friability and drug content. Ofloxacin pellets were found stable during stability study. In vitro dissolution study of ofloxacin pellets demonstrated that drug dissolution was reliant upon the physicochemical properties of the drug and more specifically on drug’s aqueous solubility, coating compositions and coating levels. Aceclofenac pellets were hot melt coated using cow ghee and ethyl cellulose. Hot melt coated aceclofenac pellets showed good flow property and pass the tests like friability, hardness and drug content. Aceclofenac pellets release profile demonstrated more than 65% release in 4 hours. Since the method used for hot melt coating did not facilitate more than 10% of coating composition, further retardation of aceclofenac release could not be achieved. Stability study showed no major change in physicochemical characteristic and dissolution.
Key Words : Ofloxacin, Pellets, Physicochemical, friability, hardness, flow property

Cite This Article:

Please cite this article in press Khan Fahaad Hassan et al, Design Of Sustained Release Pellets Of Ofloxacin Using Hot Melt Coating Technique., Indo Am. J. P. Sci, 2022; 09(6).,

Number of Downloads : 10


1. Vyas SP, Khar RK. Controlled Drug Delivery: Concepts and Advances.1st ed. New Delhi (India): Vallabh Prakashan; 2002. p. 1-14.
2. Jain NK. Novel and Controlled Drug Delivery Systems. 1st ed. Delhi (India): CBS Publishers and Distributors; 2005. p.1-15.
3. Armstrong NA. Modified Release Dosage Forms. In: Aulton ME editor.Pharmaceutics: The Science of Dosage Form Design. 1st ed. New York: Churchill Livingstone; 1997. 289-306.
4. Porter SC, Bruno CH. Sustained release dosage forms. In: Lieberman HA, Lachman L, Schwartz JB. Pharmaceutical Dosage Forms: Tablets. 2nd ed. Vol. 3, New York: Marcel Dekker Inc; 1990.p. 205-8.
5. Brahmankar DM, Jaiswal SB. Controlled release medications. Biopharmaceutics and Pharmacokinetics: Treaties. 1st ed. Delhi (India): Vallabh Prakashan;2008. 335-41.
6. Ghebre-Sellassie I. Pharmaceutical Pelletization Technology. 1st ed. NewYork; Marcel Dekker Inc; 1989. p. 1-10.
7. Conine JW, Hadley HR. Preparation of small solid pharmaceutical spheres. Drug Cos Ind. 1970; 106:38-41.
8. Robinson JR, Lee VH. Controlled Drug Delivery: Fundamentals and Applications. 2nd ed. New York: Marcel Dekker Inc; 1987. p.373.
9. Bechgaard H, Ladefoged K. Distribution of pellets in the gastrointestinal tract. JPharm Pharmacol.1978; 30(11):690- 2.
10. Bechgaard H. Critical factors influencing gastrointestinal absorption-what is the role of pellets? Acta Pharm Technol.1982; 28(1): 149-57.
11. Bechgaard H, Hagermann NG. Controlled release multiple-units and single unit doses. A literature review. Drug Dev Ind Pharm. 1978; 4(1): 53-67.
12. Chavanpatil MD, Jain P, Chaudhari S, Shear R, Vavia PR. Development of sustained release gastro retentive drug delivery system for ofloxacin: in vitro and in vivo evaluation. Int J Pharm. 2005; 304(1-2):178-84.
13. Handbook of Pharmaceutical Excipients. Editors: Rowe, Raymond C, Sheskey, Paul J, Cook, Walter G, Fenton, Marian E. Stearic acid and palmitic acid. 4th ed. London (UK): Pharmaceutical Press; 2003. p. 615-7.
14. Yar MS, Siddiqui AA, Ali MA, Manogran E. Design of targeted dosage form of ofloxacin. J Serb Chem Soc. 2006; 71 (12): 1269-73.
15. Cui Y, Zhang Y, Tang X. In vitro and in vivo evaluation of ofloxacin sustained release pellets. Int J Pharm. 2008; 360: 47-52.
16. Tiwari D, Kheri R. Preformulative studies for floating tablet of ofloxacin. Int J Pharm Life Sci. 2010; 1(7):419-27.
17. Dumpeti J, Joginapally S, Bharat V, Subramaniyan PR. Formulation and evaluation of gastroretentive drug delivery system for ofloxacin. Int J Pharm.